Filed: 8/11/2023ACC: 0000904454-23-000482
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $289.06M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$289.06M
Total AUM (reported)
20.79M
Total Shares
Allocation by class
COM$192.66M66.7%
SHS$21.67M7.5%
COM NEW$17.08M5.9%
SPON ADR$16.54M5.7%
CLASS A ORD$15.40M5.3%
SPONSORED ADR$12.47M4.3%
ORD SHS$11.89M4.1%
Portfolio Concentration
Top 3$63.97M22.1%
4–10$113.52M39.3%
11–25$111.14M38.4%
Rest$432.6K0.1%
Top 3 weight
22.1%
Top 10 weight
61.4%
Voting Authority Distribution
Total shares with voting rights: 20.79M
Sole
Full voting authority
20.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares241.69K
TypeSH
Market value$22.02M
7.62%
Sole
241.69K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares317.30K
TypeSH
Market value$21.67M
7.50%
Sole
317.30K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares846.95K
TypeSH
Market value$20.28M
7.02%
Sole
846.95K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares357.76K
TypeSH
Market value$16.82M
5.82%
Sole
357.76K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.33M
TypeSH
Market value$16.65M
5.76%
Sole
1.33M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares406.86K
TypeSH
Market value$16.54M
5.72%
Sole
406.86K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares287.56K
TypeSH
Market value$16.49M
5.70%
Sole
287.56K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares608.63K
TypeSH
Market value$15.96M
5.52%
Sole
608.63K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares492.55K
TypeSH
Market value$15.66M
5.42%
Sole
492.55K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares302K
TypeSH
Market value$15.40M
5.33%
Sole
302K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares797.53K
TypeSH
Market value$14.37M
4.97%
Sole
797.53K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares125.46K
TypeSH
Market value$14.37M
4.97%
Sole
125.46K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares139.77K
TypeSH
Market value$12.47M
4.32%
Sole
139.77K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares369.09K
TypeSH
Market value$12.04M
4.17%
Sole
369.09K
Shared
0.00
None
0.00
CLARIVATE PLC
SOLEShares1.25M
TypeSH
Market value$11.89M
4.11%
Sole
1.25M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares761.72K
TypeSH
Market value$11.70M
4.05%
Sole
761.72K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares411.50K
TypeSH
Market value$10.21M
3.53%
Sole
411.50K
Shared
0.00
None
0.00
BAUSCH HEALTH COS INC
SOLEShares1.17M
TypeSH
Market value$9.32M
3.22%
Sole
1.17M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares701.57K
TypeSH
Market value$8.81M
3.05%
Sole
701.57K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$5.04M
1.74%
Sole
961.25K
Shared
0.00
None
0.00
ARES ACQUISITION CORP
SOLEShares504.71K
TypeSH
Market value$403.8K
0.14%
Sole
504.71K
Shared
0.00
None
0.00
BRIDGETOWN HOLDINGS LTD
SOLEShares895K
TypeSH
Market value$222.0K
0.08%
Sole
895K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP V
SOLEShares612K
TypeSH
Market value$110.2K
0.04%
Sole
612K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VI
SOLEShares540K
TypeSH
Market value$97.2K
0.03%
Sole
540K
Shared
0.00
None
0.00
FIRST LIGHT ACQUISITION GROUP INC
SOLEShares655.20K
TypeSH
Market value$85.2K
0.03%
Sole
655.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 241.69K | SH | $22.02M 7.62% | 241.69K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 317.30K | SH | $21.67M 7.50% | 317.30K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 846.95K | SH | $20.28M 7.02% | 846.95K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 357.76K | SH | $16.82M 5.82% | 357.76K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.33M | SH | $16.65M 5.76% | 1.33M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 406.86K | SH | $16.54M 5.72% | 406.86K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 287.56K | SH | $16.49M 5.70% | 287.56K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 608.63K | SH | $15.96M 5.52% | 608.63K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 492.55K | SH | $15.66M 5.42% | 492.55K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 302K | SH | $15.40M 5.33% | 302K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 797.53K | SH | $14.37M 4.97% | 797.53K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 125.46K | SH | $14.37M 4.97% | 125.46K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 139.77K | SH | $12.47M 4.32% | 139.77K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 369.09K | SH | $12.04M 4.17% | 369.09K | 0.00 | 0.00 |
CLARIVATE PLCSOLE | ORD SHS | 1.25M | SH | $11.89M 4.11% | 1.25M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 761.72K | SH | $11.70M 4.05% | 761.72K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 411.50K | SH | $10.21M 3.53% | 411.50K | 0.00 | 0.00 |
BAUSCH HEALTH COS INCSOLE | COM | 1.17M | SH | $9.32M 3.22% | 1.17M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 701.57K | SH | $8.81M 3.05% | 701.57K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $5.04M 1.74% | 961.25K | 0.00 | 0.00 |
ARES ACQUISITION CORPSOLE | *W EXP 02/02/202 | 504.71K | SH | $403.8K 0.14% | 504.71K | 0.00 | 0.00 |
BRIDGETOWN HOLDINGS LTDSOLE | *W EXP 09/30/202 | 895K | SH | $222.0K 0.08% | 895K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VSOLE | *W EXP 10/29/202 | 612K | SH | $110.2K 0.04% | 612K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VISOLE | *W EXP 02/17/202 | 540K | SH | $97.2K 0.03% | 540K | 0.00 | 0.00 |
FIRST LIGHT ACQUISITION GROUP INCSOLE | *W EXP 03/14/202 | 655.20K | SH | $85.2K 0.03% | 655.20K | 0.00 | 0.00 |
Page 1 of 2